Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | F7 | P08709 | 3/20 | 0.65 |
| ▸ | F3 | P13726 | 3/20 | 0.65 |
| ▸ | PPARG | P37231 | 3/20 | 0.65 |
| ▸ | PPARD | Q03181 | 2/20 | 0.65 |
| ▸ | PPARA | Q07869 | 2/20 | 0.65 |
| ▸ | FABP3 | P05413 | 2/20 | 0.65 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.65 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.65 |
| ▸ | FABP4 | P15090 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6477506 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL6472470 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL4750573 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL6473134 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL20503612 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL24283496 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL6476959 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL59342 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL6477509 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL18035471 | 1.00 | TRPV1 (0.70) | TRPV1ALDH1A1KDM4EF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3880642-B1 | METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS | KETOLIPIX THERAPEUTICS GMBH (DE) | 2026-01-14 | — | — | EP | claimed |
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NANOVATION THERAPEUTICS INC. (CA) | 2026-04-30 | — | — | US | disclosed |
| US-20260102357-A1 | Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NANOVATION THERAPEUTICS INC. (CA) | 2026-04-16 | — | — | US | disclosed |
| US-20260102347-A1 | Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NANOVATION THERAPEUTICS INC. (CA) | 2026-04-16 | — | — | US | disclosed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4683905-A1 | IONIZABLE ANIONIC LIPIDS | Nanovation Therapeutics Inc. (CA) | 2026-01-28 | — | — | EP | disclosed |
| EP-3880642-B1 | METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS | KETOLIPIX THERAPEUTICS GMBH (DE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4638417-A1 | SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS | Nanovation Therapeutics Inc. (CA) | 2025-10-29 | — | — | EP | disclosed |
| EP-4638465-A1 | IONIZABLE LIPIDS WITH DEGRADABLE HEAD | Turn Biotechnologies, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4634390-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| WO-2010048536-A2 | PROCESSES FOR PREPARING LIPIDS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2009132131-A1 | AMINO LIPID BASED IMPROVED LIPID FORMULATION | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-10-29 | — | — | WO | disclosed |
| EP-1727780-A1 | PROCESS FOR PREPARING (METH)ACRYLIC ESTERS. | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005082828-A1 | METHOD FOR THE PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-09 | — | — | WO | disclosed |
| US-20050100588-A1 | Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels | BEIERSDORF AG | 2005-05-12 | — | — | US | disclosed |
| EP-0439427-B1 | Aqueous emulsions containing antioxidants | CIBA GEIGY AG (CH) | 1995-08-30 | — | — | EP | disclosed |
| US-5116534-A | AQUEOUS EMULSIONS CONTAINING ANTIOXIDANTS | CIBA-GEIGY CORPORATION (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0439427-A1 | Aqueous emulsions containing antioxidants | CIBA-GEIGY AG (CH) | 1991-07-31 | — | — | EP | disclosed |
| US-4440940-A | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-04-03 | — | — | US | disclosed |
| US-4230878-A | AND 4-(UNSATURATED ALKYL)AMINOBENZOIC ACIDS AND DERIVATIVES | AMERICAN CYANAMID COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102357-A1 | Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | SGMS1, SGMS2, NSUN2 | TRPV1 3307/4885ALDH1A1 3109/4885KDM4E 3300/4885 |
| US-20050100588-A1 | Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels | PLOD3, COL14A1, LCP1 | TRPV1 1069/4885ALDH1A1 1266/4885KDM4E 1336/4885 |
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | SLC43A1, SLC7A1, SLC7A5 | TRPV1 4530/4885ALDH1A1 2734/4885KDM4E 4032/4885 |
| US-20260102347-A1 | Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NSUN2, SGMS2, SGMS1 | TRPV1 3688/4885ALDH1A1 3276/4885KDM4E 3583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.